CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.
about
Early events associated with infection of Epstein-Barr virus infection of primary B-cellsTranscription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunityEBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40.CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals.LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cellsP-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseasesEBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 inductionAssessment of the effect of TLR7/8, TLR9 agonists and CD40 ligand on the transformation efficiency of Epstein-Barr virus in human B lymphocytes by limiting dilution assay.Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation.Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma.Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.
P2860
Q28476230-5AF81261-C094-41E4-B2F1-9AB7FCC86B31Q28593951-B6C96C71-3B0D-4F6A-9A10-1B17D6DB2CABQ30837949-8354E6EF-F384-44B2-9212-469ECEB83B4DQ33834753-1F6E6736-E099-41D6-AD85-48CF9956F823Q34542208-E9C66797-1473-408E-B7CD-ACE03A1F6221Q35242466-32394DEE-DC61-4969-97A0-8F2D6D474EBFQ35857336-319AE858-9CD4-42B8-BE07-F1B3C67B72E7Q36201459-4EDC575D-0679-4178-8646-F82553672787Q36323885-BE771EB9-7683-4379-B490-9C199B43109EQ36718160-C725BC6B-0BCE-4343-84A1-0B98B29F6876Q37456672-5BA69659-CD9F-4740-AD21-C57BA55B7801Q39288709-48AF77CD-5824-436D-A1BF-AE0A0DF191F5Q39704018-058F4431-5662-469E-A90F-080C80CE798CQ40220428-9F086F94-6F12-4F0B-B7AF-840E5F46175B
P2860
CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
CD40 ligand is a critical effe ...... l survival and transformation.
@ast
CD40 ligand is a critical effe ...... l survival and transformation.
@en
type
label
CD40 ligand is a critical effe ...... l survival and transformation.
@ast
CD40 ligand is a critical effe ...... l survival and transformation.
@en
prefLabel
CD40 ligand is a critical effe ...... l survival and transformation.
@ast
CD40 ligand is a critical effe ...... l survival and transformation.
@en
P2093
P2860
P356
P1476
CD40 ligand is a critical effe ...... l survival and transformation.
@en
P2093
Ken-Ichi Imadome
Masaki Shirakata
Norio Shimizu
Shigeaki Nonoyama
Yuji Yamanashi
P2860
P304
P356
10.1073/PNAS.1231363100
P407
P577
2003-06-12T00:00:00Z